Literature DB >> 15239297

Potential benefits of the UK Cystic Fibrosis Database.

G Mehta1, E J Sims, F Culross, J D McCormick, A Mehta.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15239297      PMCID： PMC1308802     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  12 in total

1.  Further comments on fibrosing colonpathy study.

Authors:  A Mehta
Journal:  Lancet       Date:  2001-11-03       Impact factor: 79.321

2.  Nonclassic cystic fibrosis: a clinical conundrum.

Authors:  Beryl J Rosenstein
Journal:  Pediatr Pulmonol       Date:  2003-07

3.  International comparison of median age at death from cystic fibrosis.

Authors:  A Fogarty; R Hubbard; J Britton
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

4.  Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Authors:  P M Farrell; M R Kosorok; M J Rock; A Laxova; L Zeng; H C Lai; G Hoffman; R H Laessig; M L Splaingard
Journal:  Pediatrics       Date:  2001-01       Impact factor: 7.124

5.  Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee.

Authors:  J A Dodge; S Morison; P A Lewis; E C Coles; D Geddes; G Russell; J M Littlewood; M T Scott
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

6.  Clinical outcomes of newborn screening for cystic fibrosis.

Authors:  D L Waters; B Wilcken; L Irwing; P Van Asperen; C Mellis; J M Simpson; J Brown; K J Gaskin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

7.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

Authors:  M Corey; F J McLaughlin; M Williams; H Levison
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

8.  Variant cystic fibrosis phenotypes in the absence of CFTR mutations.

Authors:  Joshua D Groman; Michelle E Meyer; Robert W Wilmott; Pamela L Zeitlin; Garry R Cutting
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

9.  Demographics of the UK cystic fibrosis population: implications for neonatal screening.

Authors:  Jonathan McCormick; Michael W Green; Gita Mehta; Frank Culross; Anil Mehta
Journal:  Eur J Hum Genet       Date:  2002-10       Impact factor: 4.246

10.  A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients.

Authors:  M Robson; J Abbott; K Webb; M Dodd; J Walsworth-Bell
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139
View more
  8 in total

Review 1.  The potential of UK clinical databases in enhancing paediatric medication research.

Authors:  Ian C K Wong; Macey L Murray
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

2.  Adult cystic fibrosis patients' experiences of primary care consultations: a qualitative study.

Authors:  Karen Lowton; Karen D Ballard
Journal:  Br J Gen Pract       Date:  2006-07       Impact factor: 5.386

3.  A methodology to establish a database to study gene environment interactions for childhood asthma.

Authors:  Stephen W Turner; Jon G Ayres; Tatiana V Macfarlane; Anil Mehta; Gita Mehta; Colin N Palmer; Steve Cunningham; Tim Adams; Krishnan Aniruddhan; Claire Bell; Donna Corrigan; Jason Cunningham; Andrew Duncan; Gerard Hunt; Richard Leece; Una MacFadyen; Jonathan McCormick; Sally McLeish; Andrew Mitra; Deborah Miller; Elizabeth Waxman; Alan Webb; Slawomir Wojcik; Somnath Mukhopadhyay; Donald Macgregor
Journal:  BMC Med Res Methodol       Date:  2010-12-06       Impact factor: 4.615

4.  A longitudinal study of the impact of social deprivation and disease severity on employment status in the UK cystic fibrosis population.

Authors:  David C Taylor-Robinson; Rosalind Smyth; Peter J Diggle; Margaret Whitehead
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

5.  Data Resource Profile: The UK Cystic Fibrosis Registry.

Authors:  David Taylor-Robinson; Olia Archangelidi; Siobhán B Carr; Rebecca Cosgriff; Elaine Gunn; Ruth H Keogh; Amy MacDougall; Simon Newsome; Daniela K Schlüter; Sanja Stanojevic; Diana Bilton
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

6.  Diabetes as a determinant of mortality in cystic fibrosis.

Authors:  Parinya Chamnan; Brian S F Shine; Charles S Haworth; Diana Bilton; Amanda I Adler
Journal:  Diabetes Care       Date:  2009-11-16       Impact factor: 19.112

7.  Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study.

Authors:  Doug L Forrester; Alan J Knox; Alan R Smyth; Andrew W Fogarty
Journal:  J Cyst Fibros       Date:  2012-09-05       Impact factor: 5.482

8.  The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study.

Authors:  David C Taylor-Robinson; Rosalind L Smyth; Peter J Diggle; Margaret Whitehead
Journal:  Lancet Respir Med       Date:  2013-01-30       Impact factor: 30.700
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.